Species: Actinomyces viscosus (HMT-0688) Primary Body Site: Oral
Download Options
LINKS: Ecology Home
| HMT-0688: [Body Sites Data]
[Taxon Description]
| Life Page: Actinomyces viscosus
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.07 | 0.09 | 0.06 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0.01 | 0 | 0 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0.02 | 0.03 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 |
| 90thp | 0.11 | 0.18 | 0.13 | 0.03 | 0.04 | 0 | 0.01 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0.03 | 0 | 0.02 | 0 | 0 |
| Stdev | 0.05 | 0.06 | 0.05 | 0.02 | 0.02 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0.02 | 0 | 0 |
| Prev(%) | 8.33 | 11.39 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
Notes:
reads equally close to A. viscosus and A. sp. HMT 171 were assigned half to each taxon
reads equally close to A. viscosus and A. sp. HMT 171 were assigned half to each taxon
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.73 | 0.79 | 0.01 | 0.03 | 0.01 | 0.03 | 0.09 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 2.37 | 1.83 | 0.02 | 0.10 | 0.04 | 0.05 | 0.02 | 0.01 | 0 | 0 |
| Stdev | 1.34 | 1.38 | 0.04 | 0.10 | 0.02 | 0.12 | 0.72 | 0.01 | 0 | 0 |
| Prev(%) | 85.71 | 88.31 | 16.88 | 45.45 | 41.56 | 38.96 | 16.88 | 19.48 | 9.09 | 1.30 |
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
No Notes
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.11 | 0.17 | 0.05 | 0.14 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.23 | 0.45 | 0.09 | 0.41 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0.30 | 0.34 | 0.18 | 0.30 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 57.62 | 75.50 | 27.97 | 60.96 | 24.83 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
Notes:
Neither HMT-175 nor HMT-688 were present singularly so these reads were split evenly at these sites (ANA,HPA,LRC,PTO,RAF,SAL,THR).Because HMT-171 is not present individually, all equidistant reads were assigned to HMT-688 at these sites (LAF,RRC).
Neither HMT-175 nor HMT-688 were present singularly so these reads were split evenly at these sites (ANA,HPA,LRC,PTO,RAF,SAL,THR).Because HMT-171 is not present individually, all equidistant reads were assigned to HMT-688 at these sites (LAF,RRC).
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0 | 0 | 0 | 0.13 | 0.05 | 0.03 | 0.04 | 0 | 0.06 | 0.06 | 0.10 | 0.23 | 0.12 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0 | 0 | 0 | 0.32 | 0.10 | 0.04 | 0.05 | 0 | 0.11 | 0.09 | 0.13 | 0.51 | 0.28 | 0 | 0 | 0 | 0 |
| Stdev | 0 | 0 | 0 | 0 | 0.25 | 0.10 | 0.17 | 0.28 | 0 | 0.25 | 0.28 | 0.49 | 0.50 | 0.33 | 0 | 0 | 0 | 0 |
| Prev(%) | 0 | 0 | 0 | 0 | 75.45 | 61.01 | 26.17 | 38.20 | 0 | 46.74 | 36.31 | 32.41 | 56.55 | 51.33 | 0 | 0 | 0 | 0 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0.14 | 0.15 | 0.01 | 0.02 | 0.02 | 0 | 0 | 0.05 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.24 | 0.41 | 0.01 | 0.04 | 0.06 | 0.01 | 0.01 | 0 | 0 | 0 |
| Stdev | 0.41 | 0.25 | 0.02 | 0.03 | 0.03 | 0.01 | 0.01 | 0.27 | 0 | 0 |
| Prev(%) | 90.54 | 97.06 | 58.14 | 82.86 | 71.43 | 42.00 | 24.24 | 32.26 | 2.50 | 0 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes
